Van Hauwermeiren Timothy 4
4 · Lexeo Therapeutics, Inc. · Filed Jun 30, 2025
Insider Transaction Report
Form 4
Van Hauwermeiren Timothy
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-26+22,916→ 22,916 totalExercise: $4.18Exp: 2035-06-25→ Common Stock (22,916 underlying)
Footnotes (1)
- [F1]100% of the shares underlying the option shall vest, and become exercisable, on the earlier of June 26, 2026, or the date of the Issuer's next annual stockholders meeting, subject to the Reporting Person's continuous service on such date.